Related Experiment Videos

Intracardiac mural thrombus mimicking atrial myxoma in the antiphospholipid syndrome

E Gertner1, J W Leatherman

  • 1Section of Rheumatology, St. Paul-Ramsey Medical Center, MN 55101.

Insights

Antiphospholipid syndrome (APS) can cause cardiac issues. Researchers found intracardiac mural thrombus, often mistaken for atrial myxomata, may be an APS manifestation.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pathology

Background:

  • Antiphospholipid antibodies (aPL) are associated with various cardiac conditions, including valvular lesions and myocardial dysfunction.
  • These cardiac manifestations suggest a potential role within the antiphospholipid syndrome (APS).

Observation:

  • Three patients with APS (primary or with SLE) presented with right atrial masses identified via echocardiography and angiography.
  • Preoperative assessments suggested atrial myxomata.

Findings:

  • Pathological examination of resected masses revealed organized, calcified thrombus, not myxomata.
  • Follow-up ranged from 12 months to 7 years, with one case showing possible thrombus recurrence after 7 years.

Implications:

  • Intracardiac mural thrombus is proposed as an additional cardiac manifestation of APS.
  • Distinguishing these thrombi from atrial myxomata poses diagnostic challenges.

Related Concept Videos